IVF clinics misleading women over ‘fertility predicting’ test, researchers claim

IVF clinics are increasingly pushing anti-mullerian hormone assessment as a fertility test even though it cannot reliably predict the chances of conceiving, researchers say.
The anti-mullerian hormone (AMH) test can be helpful in fertility treatment as it provides an approximation of the number of eggs that may be retrieved after ovarian stimulation for IVF or egg freezing, according to researchers led by Dr Tessa Copp (PhD).
But it does not assess egg quality or predict the specific age of menopause for individual women, they say.
Dr Copp told AusDoc the tests were often promoted as a tool for women to find out about their fertility potential.